Check if your research matches the topics covered in Anti-Cancer Drugs?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Researcher.Life is built on Editage's in-depth understanding of what researchers need during publication and beyond, accumulated over 20 years.
Anti-Cancer Drugs is an international medical journal, which aims to promote and encourage research on anti-cancer agents. It was first published in 1990 and it includes reports on clinical and experimental research results, from conventional cytotoxic chemotherapy to hormonal or biological response modalities. The journal has 10 issues per year and the current editor in chief is Mels Sluyser. According to the 2014 Journal Citation Reports, the journal has an impact factor of 1.784, ranking it 164th out of 211 in the category Oncology and 162nd out of 254 in the category Pharmacology & Pharmacy. Less
Overview | |
Publisher | LIPPINCOTT WILLIAMS & WILKINS |
Language | English |
Frequency | Monthly |
General Details | |
Language | English |
Frequency | Monthly |
Publication Start Year | 1990 |
Publisher URL | Visit website |
Website URL | Visit website |
Upload your Manuscript to get
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
Anti-Cancer Drugs has been in operation since 1990 till date.
Anti-Cancer Drugs published with a Monthly frequency.
In 2023, Anti-Cancer Drugs publsihed 86 articles.
For Anti-Cancer Drugs, eISSN is 1473-5741 and pISSN is 0959-4973.
Citescore for Anti-Cancer Drugs is 5.2.
H Index for Anti-Cancer Drugs is 98.
SNIP score for Anti-Cancer Drugs is 0.52.
SJR for Anti-Cancer Drugs is Q3.
LIPPINCOTT WILLIAMS & WILKINS is the publisher of Anti-Cancer Drugs.